Therapeutics: Metabotropic glutamate receptor subtype 5 (mGluR5; GRM5)

Neurology

INDICATION: Alzheimer's disease (AD)

Mouse studies suggest mGluR5 antagonists could help treat AD. In two

Read the full 147 word article

How to gain access

Continue reading with a
two-week free trial.